Friday Favorites: Should We Be Concerned About Ochratoxin and Aflatoxin?
NutritionFacts.org Video Podcast
Michael Greger, M.D. FACLM
4.8 • 951 Ratings
🗓️ 6 June 2025
⏱️ 7 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Okrotoxin has been described as toxic to the immune system, developing fetus, kidneys, |
| 0:14.9 | and nervous system as well as being carcinogenic. |
| 0:18.1 | But that's in animal studies. |
| 0:20.5 | Okrotoxin causes kidney toxicity in certain animal species, but there's little documented |
| 0:25.0 | evidence of adverse effects in humans. That's why it's only considered a possible |
| 0:29.9 | human carcinogen. Big Ag assures that current okrotoxin levels are safe, even among those who |
| 0:35.8 | eat a lot of contaminated foods, the worst-case |
| 0:38.7 | scenario, maybe young children eating a lot of oat-based cereals. But even then, their lifetime |
| 0:44.1 | cancer risk is considered negligible, with those arguing against regulatory standards suggesting |
| 0:49.5 | you can eat more than 42 cups of oatmeal a day and not worry about it. |
| 0:56.2 | Where do they get these kinds of estimates? |
| 1:00.5 | They determine the so-called benchmark dose in animals, |
| 1:03.7 | the dose of the toxin that gives a 10% increase in pathology, |
| 1:06.0 | and then because you want to err on the side of caution, you divide that dose by 500 as a kind of safety fudge factor |
| 1:10.4 | to develop the tolerable daily intake. |
| 1:13.9 | For cancer risk, you can find the tumor dose, the dose that increases tumor incidence in |
| 1:19.5 | lab animals by 5%, and extrapolate down to the negligible cancer risk intake, effectively |
| 1:25.7 | incorporating a 5,000-fold safety factor. |
| 1:29.0 | Seems kind of arbitrary, right? |
| 1:31.5 | But what else you're going to do? |
| 1:33.0 | I mean, you can't just intentionally feed people the stuff and see what happens, |
| 1:36.4 | though, hey, look, people eat it all the time. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Michael Greger, M.D. FACLM, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Michael Greger, M.D. FACLM and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

